Pathologic findings associated with interleukin-2—Based immunotherapy for cancer: A postmortem study of 19 patients
- 30 April 1990
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 21 (5) , 493-502
- https://doi.org/10.1016/0046-8177(90)90005-p
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patients.Journal of Clinical Oncology, 1989
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- Fournier gangrene: diagnosis with scrotal US.Radiology, 1988
- Hypothyroidism after Treatment with Interleukin-2 and Lymphokine-Activated Killer CellsNew England Journal of Medicine, 1988
- Metastatic Renal Cancer Treated with Interleukin-2 and Lymphokine-Activated Killer CellsAnnals of Internal Medicine, 1988
- Dermatologic changes associated with interleukin 2 administrationJAMA, 1987
- Effects of Interleukin-2 on Renal Function in Patients Receiving Immunotherapy for Advanced CancerAnnals of Internal Medicine, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coliScience, 1984
- Structure and expression of a cloned cDNA for human interleukin-2Nature, 1983